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Background: Acute pulmonary embolism (APE) is a potentially severe medical condition 
with blood clots obstructing the pulmonary arterial vasculature. In most cases the APE 
resolves without any sequelae after anticoagulation therapy. In some patients, however, the 
emboli do not resolve upon treatment and the remnants cause increased vascular resistance, a 
condition known as chronic thromboembolic pulmonary hypertension (CTEPH). Both APE 
and CTEPH have a non-specific clinical presentation and imaging is an important part of the 
diagnosis. In APE computed tomography pulmonary angiography (CTPA) is the diagnostic 
gold standard, although the method is not suitable for all patients. CTPA has a high 
specificity for CTEPH, but the sensitivity remains under debate. At present CTPA is not 
recommended as a first line test among patients with a clinical suspicion of CTEPH. 
Purpose: To investigate unestablished imaging modalities in the diagnosis of APE (Study I) 
and CTEPH (Study III) including learning aspects (Study II) and knowledge (Study IV) of 
theses among radiologists. Regarding APE we studied magnetic resonance imaging (MRI) 
and in CTEPH we studied CTPA. 
Material and methods: Studies I-II were based on a prospective collection of 70 unenhanced 
MRI exams with CTPA as the gold standard. In Studies III-IV we used a retrospective 
material based on 43 CTPA exams from patients with confirmed CTEPH referred for pre-
surgical assessment at a specialist centre, with a matched control with suspected APE.  
Results: All MRI exams were of diagnostic quality. Specificity was 100% for both readers 
and sensitivity 90% and 93% respectively with a nearly perfect inter-reader agreement (kappa 
0.97) (Study I). Residents interpreting the MRI exams within the training program reached a 
clinically acceptable level after approximately 50 examinations and review time was halved 
during the training program (Study II). The sensitivity for CTEPH on CTPA reviewed by two 
experts was 100% and the specificity 100% (Study III), while the sensitivity based on the 
original reports from the same cases was 26% (Study IV). 
Conclusions: Unenhanced MRI has a high sensitivity and specificity for APE (Study I) and 
residents can learn to interpret such exams by using a self-directed training program (Study 
II). Enhanced CTPA has a high sensitivity when reviewed by experienced radiologists (Study 
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Deep venous thrombosis (DVT) and acute pulmonary embolism (APE) are different 
manifestations of the same disease, usually referred to as venous thromboembolism (VTE). 
VTE is usually caused by a combination of hypercoagulability, stasis of blood flow and 
endothelial damage usually referred to as the triad of Virchow (1).  APE usually originates 
from a thrombosis in the deep veins of the leg that has migrated to the pulmonary arteries. 
After myocardial infarction and stroke, APE is the third most common cause of death from 
cardiovascular disease (2). Imaging is an essential part of the diagnostic work-up, since the 
clinical presentation of APE is non-specific (3). Computed tomography pulmonary 
angiography (CTPA) is presently the primary radiological investigation in clinical practice 
and has recently been accepted as the gold standard within research (4, 5). CTPA has a high 
sensitivity and specificity for APE, it is widely available and the acquisition time is short. 
However, the administration of iodinated contrast media and the exposure to ionising 
radiation are potential limitations (6). Recent technical improvements suggest magnetic 
resonance imaging (MRI) as an option when CTPA is contraindicated, but it is not fully 
accepted as a diagnostic method for APE as yet (6, 7).  
In most patients with APE the emboli resolve without any sequelae. However, in some 
patients the embolus does not resolve but develop into endothelial fibrotic obstructions. The 
results are increased vascular resistance, pulmonary hypertension (PH) and right heart failure 
(8, 9), a condition known as chronic thromboembolic pulmonary hypertension (CTEPH). The 
cause of this process remains unknown (8, 9), but associated conditions are thrombophilic 
disorders and splenectomy (10). The clinical manifestation is usually non-specific and 
associated with the PH. It is important to distinguish CTEPH from other forms of PH since it 
is the only one that can be cured (11), but for a number of reasons the diagnosis is often 
delayed (12, 13). 
The rapid development in radiology in response to the current technical development requires 
a continuous training throughout the career among radiologists. However, the expertise on 
how to train radiology residents is limited (14) and the availability of continuous learning 
programs for radiologists even more so. These aspects are of great importance when 











Most data on epidemiology, risk factors and natural history of APE is based on studies 
investigating the entire entity of VTE (4). According to the 2019 European Society of 
Cardiology (ESC) guidelines on the diagnosis and management of APE, the annual incidence 
of APE has been estimated to be 39-115 per 100 000 people (15). In Sweden, the incidence of 
PE in 2004 was 20-60 per 100 000 and 10-15 per 100 000 lethal APE incidences determined 
by autopsy (16). However, the incidence has increased in many countries in recent years due 
to improved diagnostics; in Sweden for example, the National Board of Health and Welfare’s 
database indicates an increase from 43 to 64 per 100 000 patients admitted to hospital due to 
PE between the years 2004 and 2018 (17). 
The mortality rate in APE differs from >15% in haemodynamically unstable patients, 3-15% 
in intermediate risk patients with right ventricular dysfunction or myocardial damage and 
<1% in low risk patients (18). This indicates the importance of distinguishing the relatively 
small group of haemodynamically unstable high-risk patients from the normotensive 
intermediate- or low-risk patients (18, 19). 
There is no agreement on whether VTE varies according to gender (2). In young patients, 
however, there seems to be a female predominance, probably due to hormonal factors such as 
oral contraceptives and pregnancy (16). VTE can be provoked by reversible risk factors such 
as surgery, trauma, immobilisation, pregnancy and hormonal treatments up to three months 
prior to diagnosis (4). Malignancy is also a major risk factor although the risk of VTE varies 
with different types and stages of cancer: Pancreas, gynaecological, lung, stomach, kidney 
and primary brain cancer showing the highest risk (20, 21). The existence of reversible risk 
factors is important since it is taken into consideration regarding duration of anticoagulation 




CTEPH was previously considered to occur in 0.1– 0.5% of APE survivors (23). However, 
more recent studies indicate that it is a rather common complication of APE ranging from 
2.8% and 4.8% with most cases occurring within two years of the initial event (23-25). It 
should also be noted that about 25% of CTEPH patients have no previously known history of 
VTE according to the International CTEPH Registry (26). Risk factors for developing 
CTEPH include thrombophilic disorders seen in 32% and splenectomy reported in 3.4% of 




2.2 CLINICAL PRESENTATION  
2.2.1 APE 
The clinical presentation of APE is nonspecific but includes symptoms like chest pain, cough, 
dyspnoea, fever, hemoptysis, tachycardia or even cardiogenic shock. Chest pain is relatively 
common and caused by pleural irritation associated with infarction due to peripheral emboli. 
Central or extensive embolization may present with haemodynamic instability or syncope. 
However, sometimes APE occurs as an incidental finding on computed tomography (CT) in 
asymptomatic patients.  
 
2.2.2 CTEPH 
The symptoms of CTEPH are nonspecific and other more common causes are usually 
considered first, leading to delayed diagnosis and treatment (27). The clinical presentation 
usually reflects the degree of PH (8, 11). Among the symptoms described are exertional 
dyspnoea, atypical chest pain, chronic non-productive cough, tachycardia, syncope and cor 
pulmonale (8). The clinical presentation may resemble APE (10) and additional acute 
embolisation may also occur in patients with CTEPH ‘acute on chronic’, which makes things 
more complicated. Knowledge of risk factors and clinical presentation of APE as well as 
CTEPH is important for the radiologist when protocolling and reading examinations. 
 
2.3 DIAGNOSTIC METHODS 
Because of the nonspecific clinical presentation of APE, imaging is an essential part of the 
diagnostic work up. Since the 1990s there has been a shift from invasive investigations such 
as phlebography and pulmonary angiography to non-invasive examinations such as venous 
compression ultrasonography and CTPA (9). During the last few decades there has been a 
constant increase in CT utilisation, including a 5-fold increase in CTPA in patients with 
suspected APE between 2001-2009 (28). The proportion of CTPA exams positive for APE is 
approximately 20% (29), but recent studies from the USA indicate that less than 10% of 
patients referred for CTPA actually have APE (28). Consequently there has been an increase 
in radiation exposure as well as health care costs why diagnostic algorithms have been 
developed including clinical probability assessment tests and D-dimer (28).  
The diagnostic work up in CTEPH is more complicated than in APE. The 2015 ESC/ERS 
guidelines have presented a diagnostic algorithm for PH-patients. The first step is to perform 
echocardiography if PH is present. If suggestive of PH, the second step is to identify the 
clinically common PH groups 2 and 3 (left heart disease and lung disease respectively). At 
this point, some sort of imaging is usually performed, such as chest X-ray or high resolution 
computed tomography (HRCT). If these are negative the third step is to screen for group 4 
PH (CTEPH) using V/Q scan. If positive, it is recommended to refer patients to an expert 
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centre for further evaluation with right heart catheterisation, CTPA and potentially pulmonary 
angiography. (10) 
 
2.3.1 Clinical probability assessment tests 
It is important to distinguishing high-risk patients (signs of cardiogenic shock or hypotension) 
from low-risk patients (haemodynamically stable patients) (15). High-risk patients are 
recommended immediate CTPA, while low-risk patients are further evaluated with clinical 
probability tests combined with D-dimer to decide if CTPA is required.  
 
Table 1a 	  	  
	  
Table 1b 	  	  
Wells Score   
 




Previous VTE 1.5 
 
Previous VTE 1 
Heart rate >100 b.p.m. 1.5 
 
Heart rate 75-94 b.p.m 1 
Surgery or immobilisation last 4 weeks 1.5 
 
Heart rate >95 b.p.m 2 
Haemoptysis 1 
 
Surgery or fracture last month 1 
Active cancer 1 
 
Hemoptysis 1 
Clinical signs of DVT 3 
 
Active cancer 1 
Alternative diagnosis less likely than 
APE 3 
 
Unilateral lower limb pain 1 
    
 
Pain or oedema lower limb 1 
    
 
Age >65 years 1 
    
 
    
Three-level score   
 




Intermediate 2-6  
 




    
 
    
Two-level score   
 
Two-level score   
APE unlikely 0-4 
 
APE unlikely 0-2 
APE likely >4 
 
APE likely >2 
Table 1. a) Wells score parameters including the two- and three-category prediction. b) The 
simplified Geneva score with the two- and three-category prediction. 
 
Individual symptoms have limited sensitivity and specificity for APE, but the combination of 
findings and risk factors allows classification of patients with suspected APE into different 
risk categories according to the ESC guidelines 2019 (15) . The most commonly used clinical 
probability assessment test is the Wells score (30) where there exists both a three-category 
prediction (low, moderate or high probability of APE) and a two-category prediction (APE 
likely or unlikely), table 1a. The simplified Geneva score is also commonly used table 1b. 
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Both assessment tests have been adequately validated and regardless of which is used, 
approximately 10% in the low risk or unlikely category will have APE (15). Although, it 
should be noted that neither the Wells score or the simplified Geneva score accounts for 
estrogen related risk factors such as oral contraceptives, pregnancy or the initial postpartum 
period (first eight weeks after delivery) and has not been evaluated for these patients (31). 
However, the recent YEARS-study shows promising results for reducing diagnostic imaging 
also among pregnant women (32). According to the YEARS algorithm APE is ruled out if 
none of the criteria (clinical signs of DVT, hemoptysis and APE as the most likely diagnosis) 
were positive in combination with a D-dimer level less than 1000 ng per milliliter or if one or 




D-dimer is used as a laboratory investigation measuring a fibrin degradation product, which 
increases in cases of fibrinolysis thereby suggesting the presence of thrombosis. It has a high 
sensitivity for VTE, but the specificity is low (33). Increased D-dimer levels can also be seen 
in infections, inflammatory diseases, malignancies, pregnancy and liver failure. D-dimer 
levels also increase with age, reducing the usefulness of the test in elderly patients (34). For 
instance, D-dimer testing has been able to rule out APE in 51% of patients younger than 40 
years, but in no more than 5% of patients older than 80 years (35). In 2014 Righini et al 
presented the idea of age-adjusted D-dimer cut-off levels that actually resulted in a 5-fold 
increase in the proportion of patients older than 75 years where APE could safely be ruled out 
without any further investigations (34). Since then, age-adjusted cut-off levels regarding D-
dimer has been introduced in Swedish laboratories. 
To summarise, D-dimer and clinical probability tests can be used to exclude APE in 
approximately 30% of patients with low or intermediate risk (18). Nevertheless, in patients 
with a high clinical probability or elevated D-dimer, further investigations are required. 
 
2.3.3 Pulmonary angiography 
In 1938 a first attempt was made to visualise the cardiovascular system by an intravenous 
injection of iodine, but it was not until the mid-1960s more extensive research was made, 
including both intravenous contrast administration and selective pulmonary arterial 
angiography (36). For a long period of time pulmonary angiography was considered the gold 
standard of APE imaging (6, 37), although it recently has been replaced by CTPA (36, 38). In 




Pulmonary angiography is an invasive method where a catheter is placed into the main 
pulmonary arterial branches, with repeated contrast injections. Angiographic findings in APE 
include intraluminal filling defects, arterial cut-off, areas of oligemia and asymmetric flow 
(36). The most common findings in CTEPH are pouch defects, intimal irregularities, abrupt 
vessel narrowing and bands/webs (39). The invasive nature entails complications, with 
reported morbidity and mortality rates ranging from 3.5–6 % and 0.2–0.5 respectively (33, 
40).  
It should be noted that 1.6% of patients with a normal pulmonary angiogram develop APE 
during a one year period, half of them within eight days (41). Furthermore, the interreader 
agreement on the subsegmental level is moderate, indicating limited diagnostic accuracy in 
small arterial branches (37, 42). 
In clinical practice conventional angiography is rarely used in patients with suspected APE 
but is recommended as part of the pre-surgical assessment in CTEPH patients (10). 
 
 
Figure 1. Example of images from a pulmonary angiography. The catheter used can be seen 




2.3.4 Ventilation perfusion scintigraphy  
Ventilation perfusion scintigraphy (V/Q scan) was first introduced in the mid 1960s. In the 
1980s the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) study 
compared the results for V/Q scans with conventional pulmonary angiography. It showed that 
V/Q scans have a high sensitivity (98%), but low specificity (10%) (43). However, it was 
non-invasive unlike pulmonary angiography and in the following years scintigraphy became 
the first line diagnostic test in cases of suspected APE due to its safety. 
 
 
Figure 2. Example of a VQ-scan. 
 
In V/Q scans radioisotopes are administered and imaged by a gamma camera. Perfusion 
scintigraphy is performed with 99mTc-macroaggregated albumin (99mTc-MAA), which is 
injected into a peripheral vein. The 99mTc-MAA is distributed in the lungs according to the 
regional lung perfusion and trapped in the pre-capillary arteries (particle size 15-100 µm) 
(44). The perfusion scan is often combined with a ventilation scintigraphy, where 99mTc-
aerosols commonly are inhaled. However, there are a number of options and inert gases such 
as 81mKr and 133Xe can also be used (45). The combination of ventilation and perfusion 
increases the specificity and yields additional information about other conditions (46). 
Perfusion defects with normal ventilation (V/Q mismatch) may indicate APE or CTEPH. 
Characteristic perfusion defects are wedge shaped lobar, segmental or subsegmental with a 
distribution according to vascular anatomy. However, similar findings can be seen in several 
 
 9 
other conditions. To make things even more complicated APE can manifest as a matched 
defect in cases of pulmonary infarction. 
Apart from the low specificity, limitations for V/Q scanning include the probabilistic 
classification, the number of indeterminate exams, interobserver variability, the relatively 
long examination time and inability to detect differential diagnoses (36). In addition, the 
availability is usually limited after office hours. 
At present CTPA has replaced V/Q scans as the first line diagnostic method in patients with 
suspected APE. However, for patients with contraindications to CTPA or during pregnancy, 
it is still frequently used. Regarding CTEPH the V/Q scan is still recommended as a 
screening test in international guidelines since it can safely rule out CTEPH in PH patients 
(10). 
 
2.3.5 Computed tomography pulmonary angiography 
The CT was first introduced in the early 1970s and APE was first reported in 1978 as an 
incidental finding (36). But it was not until 1992 and a publication by Remy-Jardin that spiral 
CTPA emerged as a potential modality to detect APE (47). First-generation CT scans with 
single detector rows had a sensitivity of 53% and 91% specificity for APE (9, 38). The 
technical development, including the introduction of multidetector row CT, has improved 
image quality as well as acquisition time. In multidetector CT the sensitivity varies between 
83–100% and the specificity between 89–97% (38). One of the studies that established 
multidetector CTPA as a diagnostic option was the PIOPED II trial: A prospective 
multicentre study on 824 patients during 2001–2003 (48). It found a sensitivity of 83% and 
specificity of 96% for APE. Except for the high diagnostic accuracy CT also offers 
alternative causes of symptoms, unlike for instance V/Q scans. The clinical validity of a 
negative CTPA scan is similar to that of conventional pulmonary angiography (38). In 
addition CTPA is widely available and has a short acquisition time (4–5 seconds in a 64 row 
scanner). 
Imaging is an essential part of the diagnostic algorithm in CTEPH as well, and CT is 
mentioned as a diagnostic option in the 2015 ESC/ERS guidelines on pulmonary 
hypertension (10). Several studies have established that CT has a high specificity (93-100%) 
for CTEPH (49-54), but the sensitivity remains under debate. A study on 55 CTEPH patients 
by Bergin et al from 1997 (49) showed promising results regarding both sensitivity and 
specificity and two more recent studies on 24 and 27 CTEPH patients respectively showed a 
sensitivity of 98–100% for lobar arteries and 94–100% on the segmental level (51, 55). There 
are two more recent studies on 114 and 132 consecutive patients (51 and 78 patients with 
confirmed CTEPH diagnosis respectively) that showed sensitivities of 92–94% (52, 54). Still, 
the largest and most frequently cited study is from 2007 showed conflicting results with a 
sensitivity of only 51% for CT (50), this will be further discussed in the discussion section.  
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During CT examinations, consecutive x-ray projections from different angles of the body 
produce cross-sectional images by computer processing. For visualisation of potential emboli 
iodinated contrast media must be administered and the contrast bolus must be caught while 
within the pulmonary arteries (a time span of approximately 10 seconds) (7). 
Limitations regarding CTPA include the exposure to ionizing radiation and the administration 
of contrast media. Impaired renal function is a contraindication for CTPA and contrast allergy 
may also be a problem. Regarding pregnant patients it has been debated whether CTPA or 
V/Q scan is most appropriate (56) but according to the 2019 ESC guidelines the choice of 
imaging should be determined by local expertise and resources (15). 
The diagnostic signs of APE on CTPA are: 1) Arterial occlusion, the diameter of the 
occluded artery is often enlarged compared to surrounding vessels, fig 6. 2) Partial filling 
defect surrounded by contrast material, also known as the ’polo mint’ or ’railway track’ sign. 
3) The partial filling defect may sometimes be eccentric, but in this case it should form acute 
angles with the vessel wall. Infarctions can be seen as wedge shaped infiltrates in the 
peripheral lung regions, but this finding has a low specificity, fig 5. In addition, signs of acute 
right ventricular failure should be described, as these patients may be at risk of circulatory 
collapse. CT findings of this include right ventricular dilatation, deviation of interventricular 
septum to the left and reflux of contrast material into the hepatic veins. (57) 
In cases of CTEPH, there are several radiological features to keep in mind. These may be 
divided into direct pulmonary arterial findings, signs of PH and parenchymal signs. Among 
pulmonary arterial findings there are: 1) Complete occlusion, sometimes causing a so-called 
‘pouch defect’. Occluded vessels, particularly on the segmental and subsegmental level show 
reduced vessel diameter 2) Partial filling defects that are usually eccentric with obtuse angles 
towards the vessel wall. 3) Signs of recanalization such as bands and webs, depicted as thin 
lines surrounded by contrast material. (8, 57). 4) Calcified thrombus. Signs of PH include: 1) 
Increased diameter of the main pulmonary artery (MPA) >29 mm in men and >27 mm in 
women. 2) Increased MPA-ascending aorta (AA) ratio >1:1, since the AA widens with age 
this sign is most useful in patients <50 years. 3) Tortuous vessels. 4) Increased systemic 
collateral arteries, a non-specific sign, which however appears to be more common among 
CTEPH patients than other groups of PH patients. 5) Right heart disease is including right 
ventricular enlargement (a ratio of the right ventricle compared to the left >1:1), right 
ventricular hypertrophy (RVH) with a myocardial thickness >4 mm and interventricular 
septum deviating to the left. In severe cases there may also be pericardial thickening or a 
small pericardial effusion. Regarding parenchymal signs there are: 1) Mosaic attenuation, a 
pattern of increased and decreased attenuation of the lung parenchyma where the low 
attenuating areas represent hypoperfusion. This sign is considered non-specific, but in 
patients with PH it is usually related to CTEPH. 2) Scars, following previous infarctions. 3) 





Fig 3. Vascular signs associated with CTEPH. a) Increased diameter of the MPA (44 mm) 
and a calcified thrombus in the left lower lobe artery. b) Occlusion with reduced vessel 
diameter in segmental arteries in the left lower lobe. c) A band in the left lower lobe artery, 
visualised as a thin line surrounded by contrast. d) Eccentric thrombus in the right 
pulmonary artery.   
  
Fig 4. Mosaic attenuation, seen as areas of different attenuation in the lung parenchyma. 
 
CTEPH is considered to be frequently missed and underdiagnosed for a number of reasons 
including lack of knowledge of the condition among radiologists (11, 12) . Obviously, an 
understanding of the radiological features is required to detect the condition on exams from 
various imaging modalities.  
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At present, both the American College of Radiology, the European Society of Cardiology 
(ESC) and Fleischner Society recommend CTPA as the first line test in patients with 
suspected APE, while the Fleischner Society even suggests it as the new gold standard (38, 
58). According to 2015 ESC/ERS guidelines, CTPA is part of the diagnostic algorithm in 
patients with suspected CTEPH, but V/Q scan remains the recommended first-line screening 
option and conventional pulmonary angiography is still recommended for presurgical 
assessment (10). 
 
2.3.6 Magnetic resonance imaging 
The magnetic resonance phenomenon was first discovered in the mid-1940s but it was not 
until the 1970s that it was used to demonstrate human pathology. Magnetic resonance 
imaging (MRI) of the lungs was first introduced in the 1980s (59). Among the early 
limitations in clinical practice were limited spatial resolution, motion artefacts, long 
acquisition time and in severely ill patients, the lack of MR-compatible monitoring devices 
(60). Increasing technical development has made MRI less susceptible to these limitations. It 
has been suggested that MRI could emerge as a diagnostic option regarding APE, particularly 
in patients not suitable for CTPA (6, 61). Nevertheless, MRI is not fully accepted yet as a 
diagnostic test in patients with suspected APE due to limited sensitivity (7, 61). 
In MRI radio waves are applied to a magnetic field to produce sectional images of the body. 
Technically there are a number of different ways to visualise embolism in the pulmonary 
arteries. Gadolinum enhanced magnetic resonance angiography (Gd-MRA) is the most 
frequently studied method. It is similar to CTPA in the respect that contrast media is 
administered, however, with the longer acquisition time in MRA (15-20 seconds) it is more 
difficult to time the bolus so that all pulmonary arteries are well opacified (7). Unenhanced 
MRI sequences are also used, such as steady-state free precession (SSFP) where movement 
of the blood flow creates high signal intensity in the arteries and emboli can be detected as 
signal voids. MRI perfusion can be used to detect perfusion defects and has been described to 
have high agreement with scintigraphic methods (62).  
The findings in APE on MRI are similar to those on CTPA, since both exams visualise the 
same morphological information. Thus, occlusion and partial filling defects surrounded by 
contrast material are the main findings. Wedge-shaped perfusion defects and infarction can 
also be seen. The main difference in interpreting MRI compared to CTPA is the artefacts. 
(60, 63) 
In CTEPH the expected MRI findings are also similar to those seen on CTPA. An early study 
by Ley et al from 2003 showed that MRI is equal to CTPA on segmental level, but CTPA 
was superior on the subsegmental level and for evaluating intraluminal webs and thrombotic 
wall thickening (55). Technical advances in MRI have likely improved the diagnostic 
capability since then, but there are no recent studies comparing MRI and CTPA in CTEPH 




Fig 5. Examples of images from CTPA (left) and MRI (right) in a 83-year old patient with 
APE. Emboli can be seen in the right lower lobe artery and in the left intermediate artery 
(arrows), in addition an infarction can be seen in the right lung (bent arrow.) 
 
 
Fig 6. Examples of images from CTPA (left) and MRI (right) in a 52-year old patient with an 
isolated subsegmental embolus in the right lower lobe (arrow). Note that the affected artery 
is enlarged compared to surrounding arteries. A small pleural effusion can be seen on the 
right side. In the right lower corner magnifications illustrate the ‘polo mint sign’ 
 
There are two recent meta-analyses on the topic of MRI and APE. In 2015 Zhou et al 
published information based on 24 studies, 15 of which were patient based and 9 vessel 
based, from 1993–2013. The number of technically inadequate investigations was 19%, 
which is three times higher than in CTPA. When the technically inadequate investigations 
were excluded, MRI had a sensitivity of 78% and a specificity of 97% on a patient based 
level, which is similar to the diagnostic performance of CTPA in the PIOPED II study. 
However, 10 of 15 studies had a small sample size (<89 subjects) and 8 of 15 studies had a 
considerably higher prevalence of APE than expected, making selection bias likely; Zhou 
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finds it possible that these aspects might have made the results favourable for MRI. On a 
vessel-based level, Zhou found a high sensitivity for MRI in lobar and segmental vessels (91-
94%), but a low sensitivity (55%) on the subsegmental level. (6) 
The second meta-analysis was performed by Li et al in 2016 though it only assessed Gd-
MRA in five studies, all of which were also included in Zhou’s study. The conclusion was 
that Gd-MRA can be used to detect APE, but should not be used as a stand-alone test to 
exclude APE due to its limited sensitivity. (61) 
The most important studies in the field of MRI in the detection of APE are PIOPED III- and 
the IRM-EP studies, both of these were included in the meta-analyses by Zhou and Li (64, 
65). The PIOPED III study, a prospective multicenter study performed 2006–2008 on 371 
patients, analysed the diagnostic accuracy of Gd-MRA alone and combined with thigh 
venography in APE. The number of technically inadequate investigations was high (25%) 
ranging from 11% to 52% at different centers. The most common causes of inadequate exams 
were poor arterial opacification (67%) and motion artefacts (36%), but also MRI specific 
artefacts such as wraparound (4%) and parallel imaging artefacts (2%) occurred. Among the 
technically adequate investigations the sensitivity was 78% and specificity 99% on a patient 
based level. On a vascular level it was noted that the sensitivity decreased with vessel size, 
with a sensitivity of 79% in main or lobar arteries, 50 in segmental arteries and 0% in 
subsegmental arteries. The conclusion of PIOPED III was that Gd-MRA only should be 
considered at experienced centers and only in patients with contraindications for the standard 
diagnostic examinations. (64) 
The IRM-EP study from 2012–2013 by Revel et al was also a prospective study, performed 
at a French University Hospital during 2007-2009. The purpose of the study was to evaluate 
new MR-sequences including unenhanced and perfusion sequences in addition to MRA and 
to investigate if MRI could be used as a diagnostic test in APE-patients. The proportion of 
technically inadequate exams was 30%. Combining all MR sequences in the assessment for 
the technically adequate exams the overall sensitivity was 79–85% and the sensitivity was 
99–100%. There was a high sensitivity (98–100%) in proximal APE, but the sensitivity 
decreased with vessel size (68–91% on segmental level and 21–33 on subsegmental level). 
MRA exams had the highest sensitivity. Perfusion sequences had a slightly higher sensitivity 
than unenhanced exams, but the unenhanced exams showed a higher specificity and 
interreader agreement. (62, 65) 
MRI has the potential to be well suited for CTEPH patients as it offers evaluation of right 
ventricular function in addition to pulmonary arterial findings and alternative causes of PH 
(46). The number of studies on the topic is scarce. MRI perfusion has demonstrated similar 
sensitivity compared to V/Q scans (52) and MRI shows a high sensitivity for obstruction in 
central arteries (66). Nevertheless, CT has a higher sensitivity on the subsegmental level, in 
the detection of intraluminal webs and thrombotic wall thickening (55). In summary, the 
utility of MRI for diagnosing CTEPH has not been established as yet (63).  
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At present, according to the 2019 ESC guidelines, MRI has shown promising results for APE 
but is not ready for clinical practice (15). The reasons for this decision are the low sensitivity, 
the high proportion of technically inadequate exams and the low availability in the emergency 
setting. However, it should be mentioned that there have been advances in the MRI 
technology, including spatial resolution, since the PIOPED III and IRM-EP studies. It has 
also been argued that MRI may be useful in CTEPH patients as it enables both assessment of 
pulmonary arteries and right ventricular function but the number of studies is limited, and the 
method must be validated. (9, 46, 63). The awareness of thoracic findings on MRI has 
increased in recent years and there are studies encouraging radiologists to look for thoracic 
findings such as PE on abdominal MRIs (67). 
 
2.4 PATIENTS SUITABLE FOR MRI 
For the depiction of emboli in the pulmonary arteries on CT, intravenous administration of 
iodinated contrast media is required. In patients with severe renal impairment, iodinated 
contrast media is contraindicated since it may cause contrast-induced nephropathy. Patients 
allergic to iodinated contrast media may also cause a problem, but allergic reactions can often 
be avoided by the use of premedication. In the PIOPED II study, 19% of patients with 
suspected APE had abnormal creatinine levels and 4% were allergic to contrast agents (48). It 
has been reported that 12% of patients with elevated creatinine levels and suspected APE 
may develop contrast-induced nephropathy following CTPA (68). 
Pregnant patients have an increased risk of APE due to hormonal changes and APE is the 
leading cause of pregnancy-related mortality in developed countries (56). It has been debated 
whether CTPA or V/Q scan is most appropriate (56). The diagnostic yield for both 
examinations is similar (69), since the results for V/Q scan is better in young patients without 
any pulmonary disease, while the number of inconclusive CT scans is higher due to 
difficulties in catching the contrast bolus with the increased blood volume during pregnancy. 
Fetal radiation doses are also similar for V/Q scans and CT.  It used to be argued that the 
radiation to the maternal breast among pregnant women constituted a problem (70), but with 
ongoing technical development this is no longer the case (15). 
To summarize, patients with renal impairment and pregnant patients are among the patient 






2.5 PEDAGOGICAL ASPECTS  
During radiology residency junior physicians are educated within the field of radiology to 
become attending physicians. A high standard of quality in the residency program is 
important to achieve well-qualified radiologists. In fact, there is an established relationship 
between clinical learning environment and patient safety (71). Furthermore, with the rapid 
technical development within the field of radiology it must be argued that continuous learning 
throughout the career is required. However, a problem with radiology education is the 
scarcity of measurable data with regard to the learning process during residency (14). 
In the field of medical education, there is an ongoing transition from the traditional time-
based models to outcome-based learning models, focusing more on the final capabilities (72, 
73). American recommendations for Medical Education Reform 2010 urged updated 
pedagogy, including learning in context, mentorship, extensive feedback and time for 
personal reflection (72).  
Deliberate practice has proven useful as an educational strategy in various fields of education 
(74). In this training method the learner is 1) given a task exceeding current level of skills, 2) 
motivated to practice and improve, 3) provided with instant effective feedback, and 4) 
encouraged to reflect on the learning experience (75). In addition, the learner should perform 
the same or similar tasks repeatedly. When the method is followed, practice should improve 
both accuracy and speed of performance on cognitive, perceptual and motor skills (76).  
In medical education, deliberate practice has been suggested particularly in radiology 
training, electrocardiogram interpretation and surgery stimulation (74, 77). Visualizing the 
effect of deliberate practice by plotting learning curves with the performance against time 
spent learning, it is possible to define at which levels education is most efficient and how 
much training is required for a certain level of competence (74, 78). Accordingly, this is the 
method used in Study II. Not only is it important for radiology educators to understand how 
people learn, it has also been argued that emphasis should rather focus on learner progress 
rather than the learner’s absolute level of knowledge (79). Thus, a thorough understanding of 
learning curve effects is important to produce an ideal learning environment (79). 
Studies on learning curve effects in radiology usually focus on identifying a specific 
diagnosis or anatomical structure on certain examinations (14, 77, 78, 80). Most studies 
include either relatively few reviewers or training examinations. In addition, different 
outcome measures are used to assess improvements in diagnostic ability over time, including 
sensitivity/specificity, ROC-analysis and interreader agreement, making direct comparison 
among studies more difficult. There appears to be a general agreement that the amount of 
training is an important factor to achieve a high diagnostic accuracy (77, 78, 81), while the 
effects of previous radiologic experience on the ability to learn new radiologic methods have 
not been established (14, 80). A few studies have shown a positive effect on the review time, 
but not on diagnostic accuracy (78, 80). It could be that review time is reduced before 
improvement in diagnostic accuracy is seen. Except for Study II there is one other study 
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where the learners’ previous knowledge is scarce and in both these, a learning curve effect 
regarding accuracy is seen (14). 
In studies on MRI in the detection of APE, primarily senior, experienced radiologists have 
reviewed the exams (65, 82-85). However, in a clinical setting residents are commonly the 
primary reviewers (81). When introducing a new method, knowledge of the learning curves is 
of particular interest. In addition, the knowledge could be of general interest to improve the 




3 AIMS OF THESIS 
 
General aim 
The general aim of the thesis was to investigate emerging imaging modalities in the diagnosis 
of APE and CTEPH and the knowledge of theses among radiologists.  
3.1 STUDY I 
“Detection of pulmonary embolism using repeated MRI acquisitions without respiratory 
gating: A preliminary study.” 
The aim of the study was to determine the sensitivity and specificity of repeated 
acquisitions of unenhanced MRI in the detection of APE.  
Our hypothesis was that unenhanced MRI with repeated acquisitions could be used as a 
diagnostic test in patients with suspected APE. 
3.2 STUDY II 
“How to train radiology residents to diagnose pulmonary embolism using a dedicated MRI 
protocol.” 
The aim of the study was to evaluate if residents in radiology can be trained to review 
MRI regarding APE and to examine the learning curve effects. 
Our hypothesis was that it is possible for residents to independently learn how to interpret 
MRI regarding APE within a self-directed training program. 
3.3 STUDY III 
“Sensitivity of computed tomography pulmonary angiography for diagnosing chronic 
thromboembolic pulmonary hypertension.” 
The aim of the study was to investigate the sensitivity of CTPA in patients with CTEPH. 
Our hypothesis was that CTPA has a high sensitivity for CTEPH. 
3.4 STUDY IV 
Do radiologists detect chronic thromboembolic disease on computed tomography?  
The aim of the study was to evaluate the extent of misdiagnosis of CTEPH on CT.  
Our hypothesis was that general radiologists frequently miss CTPH findings on CT.   
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4 METHODOLOGICAL CONSIDERATIONS 
 
4.1 STUDY I 
“Detection of pulmonary embolism using repeated MRI acquisitions without respiratory 
gating: A preliminary study.” 
Study I was a prospective study approved by the regional ethical committee in Stockholm, 
Sweden (Dnr 2011/1592-31/1 and 2013/1984-32). Written informed consent was obtained 
from each participant.  
 
4.1.1 Subjects 
From February 2012 to January 2014 patients with a clinical suspicion of pulmonary 
embolism (PE) that had performed a computed tomography pulmonary angiography (CTPA) 
were given the option to participate in the study. Exclusion criteria were contraindications to 
MRI and a time span between the CTPA and MRI examinations exceeding 48 hours. 
The included patients underwent magnetic resonance imaging (MRI) within 48 hours after 
the CT exam. Participation in the study did not affect any treatment regimen, thus patients 
with APE on the CTPA received anticoagulation therapy prior to the MRI exam. One patient, 
a 51-year old woman, had a MRI incompatible breast implant and was excluded. A group of 
33 patients, 23 men and 10 women, average age 48 years, age range 22–87 years, were 
included in the study. 
Due to the time gap between the CT- and MRI exam (average time 22 hours and 39 minutes 
and time span 4 hours 28 minutes to 47 hours 22 minutes) primarily patients admitted to the 
hospital agreed to participate. Therefore, the number of patients (two men and two women) 
without PE was unproportionally low. To compensate for the small number of normal exams, 
a control group of 37 healthy subjects (nine men and 28 women; average age 48 years, age 
range 26–66 years) was created. The healthy controls underwent the MRI-exam and an equal 
number of normal CTPAs from the hospital’s patient flow were added.  
The high proportion of positive findings (patients with APE on the CTPA) in the patient 
group should be noted. A positive result of PE should be expected in no more than 10–20% 
of patients referred for CT (28, 29). Therefore, selection bias must be considered. Only two 
physicians referred patients to the study, which means that many patients with suspected APE 
probably were not invited to participate. The time gap between CT and MRI can also explain 
the selection bias. Patients asked to participate in the study that declined the offer were not 





The CTPA exams were performed by a 64-section CT scanner, Lightspeed VCT, GE 
Healthcare, Milwaukee, USA. According to a standardised protocol at the radiology 
department.  For detailed information about CT parameters and contrast administration, 
please see Study I, page 273.  
 
4.1.3 MRI-protocol 
The MRI exams were performed by a 1.5 T MRI scanner (Magnetom Aera, Siemens Medical 
Systems, Erlangen, Germany) using 2D free-breathing steady-state free precession (SSFP) 
sequences, without any intravenous contrast agent, and respiratory or cardiac gating. Unlike 
previous studies that often use cardiac and/or respiratory gating, we decided to evaluate a 
novel method using five repetitive slices in each anatomical position, to compensate for 
movements caused by respiration. The repetitive slices were sorted by position in image 
stacks. There were no specific breathing instructions. Total acquisition time was 9:34 min. 
For MRI parameters please see Study I. 
 
4.1.4 Image analysis 
All CT- and MRI exams were anonymised and blinded prior to analysis. The patient and 
control exams were also randomly mixed. The presence of APE was based on vascular signs 
only, that is complete or partial filling defects. Indirect signs, eg. infarction was not used for 
the assessment.  
A senior radiologist with more than 10 years of experience in thoracic radiology reviewed the 
CT exams and this reading was considered gold standard.  
The MRI exams were reviewed by two radiologists (R1 and R2). Both reviewers had one 
year’s experience in thoracic radiology, but R1 also had some experience in cardiac MRI. 
Both the CT- and the MRI reviewers reviewed the exams according to a standardised form 
where the vascular bed was divided into territories according to a model previously described 
by Kalb (82). If an embolus was detected, the vessels distal to it were not further evaluated. 
 
4.1.5 Statistical analysis 
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) 
were calculated with 95 percent confidence intervals (95% CI) using MedCalc Software (86). 
GraphPad Software (87) was used calculating Kappa values to determine the interreader 




4.2 STUDY II 
“How to train radiology residents to diagnose pulmonary embolism using a dedicated MRI 
protocol.” 
Study II was approved by the regional ethical committee in Stockholm, Sweden (Dnr 
2016/2392-32/1). Informed consent was obtained from each resident participating. 
 
4.2.1 Subjects 
The MRI- and CT exams from Study I were used to create a self-directed training program.  
Four radiology residents (R1–R4) performed the training program independently. Resident 
R1 had 3,5 years of experience of radiology and three weeks of prior MRI. Resident R2 had 
three years training in radiology and three weeks of general MRI. R3 had 4,5 years practice in 
radiology and three months of MRI. R4 had 2,5 years radiology training and two weeks of 
MRI. All the residents were accustomed to diagnose APE on CTPA, but they all had limited 
MRI practice. 
 
4.2.2 Image analysis 
The principles of image analysis and the report form were the same as in Study I, except that 
the review time for each MRI exam also was registered.  
 
4.2.3 Training program 
The training program constituted ten training sessions with seven MRI exams in each. 
Following each completed session, the participating resident handed in the report form and 
retrieved the reference standard including access to corresponding CT exams for comparison 
with their own reading. The reference standard was based on a consensus reading by the two 
MRI reviewers from Study 1. After comparing their own reading with the reference, the 
resident was allowed to continue on with the next session. Residents R1 and R2 performed 
the training program in the chronological order starting with session one, while R3 and R4 
took the training program in the reversed order starting with session ten. In this study we only 
examined one training program and it could be interesting in the future to compare different 
training programs and possibly add a group of residents that assessed the same investigations 




4.2.4 Statistical analysis 
Descriptive statistics including mean and range regarding review time for each resident was 
determined and p-values and r-values were calculated using Excel Data Analysis Tool Pak  
(Microsoft Office, Redmond, WA, USA). 
Sensitivity, specificity, PPV and NPV was calculated for each resident compared to the 
reference standard as well as kappa values. Due to the small size of each training session the 
sessions were paired in chronological order; that is statistics were calculated on 14 
consecutive cases.  The statistical problem with the small size training sessions could 
probably have been foreseen, but on the other hand we found it desirable with frequent 
evaluation of the residents’ reviews. 
 
4.3 STUDY III 
“Sensitivity of computed tomography pulmonary angiography for diagnosing chronic 
thromboembolic pulmonary hypertension.” 
Study III and IV were retrospective case-control studies approved by the regional ethical 
committee in Stockholm, Sweden (Dnr 2017/625-31/1). In agreement with the ethical permit 




All patients referred for pre-surgical assessment for pulmonary endarterectomy during 2011–
2016 (n=48). Patients without a prior CTPA (n=13) were excluded. The remaining 35 CTPA 
exams were performed at 23 different hospitals, so differences in CT-protocols could be 
expected. These differences and quality are one of the weaknesses of the study. Another 
weakness is that patients referred for surgery is a selected group, and they are likely to have 
relatively proximal disease. Since proximal disease will be easier to detect on CT, it is 
possible that the sensitivity was falsely high. Finally, the study population was relatively 
small and so are many of the studies in the field of CTEPH as it is considered a rare 
condition.  
4.3.1.2 Controls 
Patients examined with CTPA due to suspected APE. Each control was matched according to 




4.3.2 Image analysis 
The CTPAs from cases and controls were anonymised and mixed randomly prior to image 
analysis. Two radiologists evaluated all the CTPAs according to a standardised form. In case 
of disagreement a consensus reading was performed. 
 
4.3.3 Statistical analysis 
Sensitivity, specificity, PPV and NPV with 95% CI were calculated. Calculations were made 
on diagnostic level and for each individual sign of CTEPH. In cases of disagreement a 
consensus reading was made.  
 
4.4 STUDY IV 
“Do radiologists detect chronic thromboembolic disease on computed tomography?”  
For ethical permit, see Study III. 
 
4.4.1 Cases and controls 
The cases and controls were the same as in Study III.  
 
4.4.2 Assessment of original reports 
The original CT reports were retrieved from the picture archiving and communications 
system (PACS). The reports were evaluated according to a standardised form and the results 
were compared to a consensus reading by two thoracic radiologists. Except for radiological 
findings it was noted if the CT exam was performed in a university hospital or a non-
specialist centre.  
 
4.4.3 Statistical analysis 
Sensitivity with 95% CI was calculated on a diagnostic level and for each radiological finding 







5.1 STUDY I 
“Detection of pulmonary embolism using repeated MRI acquisitions without respiratory 
gating: A preliminary study.” 
All the CT and MRI exams were of diagnostic quality. CTPA detected 29 patients with APE, 
which was proximal in 21 patients and segmental or subsegmental in 8 patients. On MRI, the 
reviewers identified 26 and 27 patients with APE respectively. The sensitivity compared with 
CTPA was 93% (95% CI 76-99%) and 90% (95% CI 73-98%) for the readers respectively. 
Specificity was 100% (95% CI 91 - 100%) for both reviewers. PPV was 100% (95% CI 87-
100%) for both. NPV was 95% (95% CI 84-99%) and 93% (95% CI 81-99%) respectively. 
The interreader agreement between the MRI reviewers was almost perfect with a kappa value 
of 0.97 (95% CI 0.91-1.00). The two patients with false negative MRI exams underwent a 
consensus reading. It was noted that both were cases of isolated subsegmental emboli. One of 
them was seen by one of the reviewers, but in the other patient the embolus could not be seen 
even after comparison with the CTPA.  
 
5.2 STUDY II 
“How to train radiology residents to diagnose pulmonary embolism using a dedicated MRI 
protocol.” 
 
5.2.1 Agreement with reference standard 
Two residents (R3 and R4) showed an evident improvement in kappa values compared to the 
reference standard during the training program. Also R1 and R2 showed an improvement 
over time, but this finding was weaker than for R3 and R4. All residents showed very good or 
perfect inter-reader agreement after seven session or approximately 50 MRI cases.  
The improvement during the training program was mainly due to a reduction of false positive 
findings, but there was also a small decrease in false negative assessments. Session six stood 
out as more difficult than the other sessions for all residents except for R3. Thus a potential 
weakness of our model was different levels of difficulty in the different sessions. 
 
5.2.2 Review time 
The mean review time among the residents throughout the training program varied from 
03:04 minutes to 06:06 minutes, with a mean review time for all residents of 03:56 (00:13-
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12:00). However, the pattern over time was similar for three out of four residents with a steep 
decrease in time during the first three or four training sessions followed by a more gradual 
decrease. One of the residents (R3) showed a gradual decrease in reading time throughout the 
training program. The decrease in review time was statistically significant (p = 0.0002). 
 
5.3 STUDY III 
“Sensitivity of computed tomography pulmonary angiography for diagnosing chronic 
thromboembolic pulmonary hypertension.” 
The consensus reading yielded a sensitivity of 100% for CTEPH on a diagnostic level on 
CTPA. The individual sensitivities for each reviewer were 89% (95% CI 73–97%) and 94% 
(81–99%). The specificity for each reviewer was 91% (95% CI 81–99%) and 94% (95% CI 
81–99%) and in the consensus reading the specificity was 91%. The inter-reader agreement 
was kappa 0.77 (95% CI 0.66–0.92).  
Seven vascular signs associated with CTEPH were assessed and the sensitivity for these 
ranged from 6%–91%. The specificity ranged from 74–100%. 
 
5.4 STUDY IV 
“Do radiologists detect chronic thromboembolic disease on computed tomography?”  
The consensus reading from Study III with a sensitivity of 100% was used as the reference 
standard for comparison with the original CT reports. The overall sensitivity on diagnostic 
level in the original reports was 26% (95% CI 13–43). The overall sensitivity among 
university hospitals was 63% (95% CI 25–92) and among non-specialist centres 15% (95% 
CI 4-34%).  Pulmonary arterial findings without mentioning of any sign of PH had a 
sensitivity of 63% (95% CI 45-79%), isolated signs of pulmonary hypertension 53% (95% CI 






6 DISCUSSION AND CONCLUSIONS 
6.1 MAJOR FINDINGS 
The major findings from the studies included in this thesis are: 1) Unenhanced MRI using 
repetitive acquisitions instead of gating has a high sensitivity and specificity for APE. The 
method also yields a high proportion of technically adequate investigations. 2) By using a 
self-directed training program, residents can learn how to interpret dedicated MRI-exams 
regarding PE. 3) CTPA shows a high sensitivity and specificity regarding CTEPH when 
reviewed by expert radiologists. 4) There is a limited knowledge among Swedish general 
radiologists regarding CTEPH-findings on CT, leading to a falsely low sensitivity. 
 
6.2 DISCUSSION 
Combined MRI protocols have the best diagnostic performance (6), but they tend to comprise 
gadolinium-enhanced series. In 2006 Grobner et al published a small set of data on a 
relationship between gadolinium contrast administration and nephrogenic systemic fibrosis 
(NSF) (88). In pregnancy, a number of complications including neonatal death has been 
described following exposure to gadolinium contrast, while unenhanced MRI has shown no 
negative effects regardless trimester in a recent study on 1.5 million pregnancies (89). Given 
that patients with impaired renal function and pregnant patients are among the patient groups 
that could benefit the most from MRI, gadolinium-enhanced protocols are less interesting 
from a practical point of view. 
With the introduction of multidetector CT, the number of detected isolated subsegmental 
APE has increased from 5% to 9% (9). The clinical relevance of isolated subsegmental 
emboli has been questioned, not at least considering the risks associated with anticoagulation 
therapy (42). There are also concerns that CT might be overdiagnosing distal emboli, since 
conventional angiographic studies have shown a lower prevalence of 4–6% subsegmental 
emboli (38). According to the 2016 CHEST guidelines, subsegmental APE without any 
proximal DVT clinical surveillance is recommended instead of anticoagulation when the risk 
of recurring VTE is low (90). In fact, withholding anticoagulation in isolated subsegmental 
APE was suggested already in 2007 according to a statement by Fleischner Society, however, 
the statement also recommended anticoagulation in patients with inadequate cardiopulmonary 
reserve (38). To summarise, the diagnostic ability for subsegmental APE regardless of 
imaging modality is difficult to assess and the clinical significance of the low sensitivity for 
MRI on the subsegmental level is unknown. 
It is known that CT has a high specificity for CTEPH, but the sensitivity is still questioned. A 
few small studies (on 24, 27 and 55 patients each) found a high sensitivity for CT (49, 51, 
53). However, the sensitivity on the subsegmental level has not been presented in these 
studies, which is also a weakness since the sensitivity will be lower in more distal disease. 
There is also a methodological problem, as these studies only included patients with CTEPH 
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and no controls, which is likely to cause information bias. The most important study in the 
field is still the study by Tunariu et al from 2007, which is frequently cited as an argument 
against CT utilization in the diagnostic work up of CTEPH patients.  However, the cautious 
reader will notice that the CT performance was solely based on the original reports. Reports 
done by radiologists with varying levels of seniority. Thus, the Tunariu study is more likely 
to reflect the knowledge of CTEPH-findings on CT among the radiologists at that hospital 
and time than the actual sensitivity. There have also been notable technical improvements in 
CT since 2000-2005 when the material was collected.   
In Study III we found a high sensitivity for CT in CTEPH patients when reviewed by an 
expert reader. The results are similar to those by Bergin et al, Reichelt et al and Ley et al (49, 
51, 53) although we only assessed the sensitivity on a patient based level and not on a vessel 
based level. It should be mentioned that our study population included patients referred for 
surgery probably left out patients with only distal disease and this might have given a higher 
sensitivity than in an unselected material. However, the assessment on the subsegmental level 
shows a low degree of inter-reader agreement regardless of imaging modality (36), (37, 42).  
With the increasing utilisation of CT many patients with unexplained dyspnea, such as 
CTEPH patients, can be expected to have performed a CT. Unfortunately, it has been 
suggested that radiologists might have a tendency to overlook signs of CTEPH on CT unless 
specifically asked for. However, there have not been any previous studies on the topic. Study 
IV on the knowledge among Swedish radiologists showed a low sensitivity (26%), with the 
best results among CT exams reviewed at university hospitals (63%). The result among 
university hospital radiologists was similar to the Tunariu study (50). 
 
6.3 STRENGTHS  
One of the problems using MRI to diagnose APE has been the high number of technically 
inadequate investigations. The main reasons have been poor arterial opacification and motion 
artefacts (Zhou).  In Study I we introduced a method where gating was replaced by repetitive 
series and among the 70 examined patients there were no technically inadequate exams. 
Most previous studies on the sensitivity of CTPA in CTEPH patients have only had patients 
with confirmed or suspected CTEPH, which is a likely cause of information bias. We decided 
to perform a case control study instead, which improves the internal validity. 
6.4 LIMITATIONS 
As mentioned above, the sensitivity and specificity for APE using our MRI protocol was 
high. However, selection bias may have affected the results in a way favouring a high 
sensitivity. The proportion of patients with a positive finding of APE was by far exceeding 
what is seen in clinical practice and there was also a large proportion of proximal APE (21 of 
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29 patients had central or lobar APE). In addition, the study size was a bit too small, 
particularly affecting the confidence intervals regarding sensitivity. 
The time gap between the CT and MRI is also a limitation. Most studies require less than 36–
72 hours between the CT, which is performed first, and the following MRI. This is likely to 
be a result of the limited availability of MRI in emergency settings. Since the patients receive 
anticoagulant treatment in cases of confirmed APE on the CT exam or even before the CT 
exam, small emboli may have resolved by the time of MRI.  
In the second study there were only four residents evaluated, but the results from taking the 
training program were consistent. Still it could have been useful to compare the training 
program used to other teaching methods. The size of the training sessions should be 
addressed since each session was too small for individual statistical analysis. However, it was 
relevant for the residents to receive frequent feedback on their performance. 
Regarding the CTEPH studies we decided to include patients referred for the potentially 
curative surgical procedure PEA. This may cause a certain selection bias, since the patients 
referred probably will have more proximal disease, which is more easily detected on CT. 
These patients may also be younger and in a better medical condition, so that they will be 
able to undergo major surgery. However, this may be the group of CTEPH patients that is 
most important to detect early, while they are still fit for surgery.  
The total number of CTEPH patients is also relatively small, reflecting that it is a rare 
condition in the general population. This is probably the reason that several other studies in 
the field also are small. Resulting in broader confidence intervals than desired regarding 
sensitivity. Regardless of the methodological limitations there is a notable difference between 
our expert reader and the original reports, indicating that CT actually has a high sensitivity for 
CTEPH but is frequently missed by general radiologists. 
In Study IV on knowledge of CTEPH findings among radiologists, the CT exams were all 
reported in one country. It is likely that signs of CTEPH are missed on CT in other countries 










In conclusion, we have found a high sensitivity and specificity for APE and a low proportion 
of technically inadequate investigations using unenhanced MRI with repetitive acquisitions. 
In addition, we have shown that residents can learn to interpret such MRI exams 
independently using a self-directed training program. Regarding CTEPH, we have found a 
high sensitivity and specificity for CTPA exams when reviewed by an expert radiologist, but 
a limited knowledge among Swedish radiologists in general. Therefore, we suggest that 
previous CT exams in patients with suspected CTEPH should be reassessed in a specialist 
centre. A summary of the main conclusions of the thesis is provided in table 2. 
 
Table 2. Main conclusions 
• Unenhanced MRI with repetitive series has a high sensitivity and specificity for APE 
(Study I). 
• Unenhanced MRI with repetitive series shows a high proportion techically adequate 
investigations (Study I). 
• Residents can learn to interpret a dedicated MRI protocol to detect APE using a self-
directed training program (Study II). 
• CT has a high sensitivity for CTEPH when assessed by an expert reader (Study III). 
• The knowledge of CTEPH findings on CT among general radiologists is poor, 
leading to a falsely low sensitivity (Study IV). 





7 FUTURE PERSPECTIVES 
In patients with suspected APE that have contraindications to CTPA, MRI has been proposed 
as a diagnostic option for several years. In the 2019 ESC guidelines however, it is not 
accepted for clinical practice yet (15). The ACR appropriateness criteria from 2017 on the 
other hand mention pulmonary MRA together with V/Q scan as diagnostic options if CTPA 
is not available. The total number of studies in the field is still limited and most are of small 
size, while the two major studies (PIOPED III and IRM-EP) were performed more than 10 
years ago. At present there is an ongoing study investigating if the combination of a negative 
MRA in combination with a normal proximal compression ultrasound can be used to safely 
rule out APE. Given the technical development it is important with regular updates, since 
MRI after all might be introduced clinically in the upcoming years. In fact, a study by 
Schiebler et al made in 2013 used MRA as a first line investigation for APE. In this study 
95% of the exams were of diagnostic quality and during a one-year follow up period the NPV 
was 96% (91), results similar to that of CTPA. 
When it comes to the evaluation of MRI in patients with suspected APE the main focus so far 
has been on MRA. However, this is not an appropriate method for patients with impaired 
renal function or pregnant patients. Therefore, it would be desirable with a large-scale study 
on unenhanced MRI in patients in general preferably with no time gap between the CTPA 
and MRI examinations. At present there is a meta-analysis on MRI in APE patients and a 
small meta-analysis focused on MRA, when more studies are available on unenhanced MRI 
it would be desirable with a meta-analysis on this group of exams as well. 
There is no study yet on MRI to detect APE in pregnant patients. It has previously been 
recommended to avoid MRI during the first trimester, but a recent study on 1.5 million 
pregnancies exposed to MRI showed no complications during any part of pregnancy (89). 
This opens up for a study on unenhanced MRI in pregnant patients, which has a number of 
potential benefits. To start with, it offers a radiation free option to V/Q scan and CTPA. Just 
like CT MRI shows direct signs of APE and it is also able to detect severe differential 
diagnoses such as aortic dissection. Compared to CT there is no need to time a contrast bolus 
why it is possible that MRI might give a higher diagnostic yield than CTPA and V/Q scan. 
Currently, it is likely that we will see a clinical introduction of MRI in patients unsuitable for 
CTPA in the upcoming years. Nevertheless, it is possible that MRI over time will replace 
CTPA as the first line investigation in patients with suspected APE. However, the general 
availability of MRI in emergency settings must be improved first and the image acquisition 
must become faster.  
Concerning CTEPH, the 2015 ESC/ERS guidelines on pulmonary hypertension stated that 
CT is a widely available method that may suggest a diagnosis of PH and identify potential 
causes (10). The 2019 ESC guidelines on APE briefly mention CTEPH and identify CTPA as 
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a method that is “gaining ground” although VQ scan remains the first-line imaging modality 
(15). However, V/Q scans are recommended for screening and it is emphasised that most 
patients require conventional pulmonary angiography for presurgical assessment. In Study III 
we found a high sensitivity for CT in CTEPH patients and it is possible that CT will replace 
VQ-scans and conventional angiography in the future. Most patients with suspected CTEPH 
will have had a thoracic CT according to guidelines and we would consider that this is re-
evaluated at an expert centre as a first screening before ordering a VQ-scan. Nevertheless, 
further and preferably larger scale studies on CT’s diagnostic capability will be required. It 
would also be useful to compare CT-findings with conventional angiographic findings and 
surgical specimens to document the methods usefulness in the pre-surgical evaluation.  
If CT is to be introduced in larger scale regarding CTEPH patients it is important to improve 
the knowledge of CTEPH findings in the imaging community. How this is best achieved can 
be investigated in future studies on training programs among radiologists and residents. 
However, it is likely that training programs using deliberate practice or similar self-directed 
programs will be used to a larger extent in the future. There are already online training 
courses for radiologists using similar methods, one example being the TMC Academy image 
reporting simulator (92). There have been information campaigns abroad about CTEPH that 
potentially could be applied in Sweden as well.  
Hopefully, increased use of CT in the diagnostic work up of CTEPH patients and improved 
awareness of the condition will lead to earlier detection and diagnosis, with improved 








Bakgrund: Akut lungemboli är ett potentiellt allvarligt medicinskt tillstånd med blodproppar 
i lungartärerna. För det mesta brukar lungembolier upplösas utan komplikationer efter 
blodförtunnande behandling. Hos vissa patienter försvinner inte propparna och de 
kvarstående resterna orsakar ett ökat tryck i lungkärlen, ett tillstånd som är känt som kronisk 
lungembolisering, vilket medför sänkt kondition och andnöd för de drabbade. Både akuta och 
kroniska lungembolier har en ospecifik symtombild och bilddiagnostik är avgörande för att 
ställa rätt diagnos. Beträffande akuta lungembolier är datortomografi (DT) av lungartärerna 
referensmetod och kliniskt förstahandsval men metoden lämpar sig inte för alla patienter. DT 
har en hög specificitet för kronisk lungembolism men sensitiviteten är i nuläget oklar. För 
närvarande rekommenderas inte DT som ett förstahandsval för att utesluta kronisk 
lungembolism. 
Syfte: Att undersöka ännu ej etablerade bilddiagnostiska metoder för att ställa diagnoserna 
akut (Studie I) och kronisk lungemboli (Studie III) inklusive inlärningsaspekter (Studie II) 
och aktuell kunskapsnivå (Studie IV) hos röntgenläkare. Avseende akut lungembolism 
studerade vi magnetresonanstomografi (MR) och beträffande kronisk lungembolism DT. 
Material och metoder: Studierna I-II baserades på ett prospektivt material om 70 MR-
undersökningar utan kontrastmedel med DT som referensmetod. I Studierna III-IV användes 
ett retrospektivt material om 43 DT-undersökningar från patienter med konstaterad kronisk 
embolisering samt en matchad kontrollgrupp med akut lungembolism.  
Resultat: Samtliga MR-undersökningar var av diagnostisk kvalitet. Specificiteten var 100% 
för båda granskarna och sensitiviteten var 90% respektive 93% med i det närmaste perfekt 
överrensstämmelse mellan granskarna, kappa 0.97 (Studie I). ST-läkarna som genomgick ett 
träningsprogram avseende MR-undersökningar nådde en kliniskt acceptabel nivå efter ca 50 
undersökningar och granskningstiden halverades under träningsprogrammet (Studie II). 
Sensitiviteten och specificiteten för kronisk lungembolisering med DT granskat av två 
subspecialiserade radiologer var 100% (Studie III), medan sensitiviteten baserat på 
originalutlåtandena från samma undersökningar endast var 26% (Studie IV). 
Slutsats: MR utan kontrastmedel har en hög sensitivitet och specificitet för akut 
lungembolism (Studie I) och ST-läkare kan lära sig att granska sådana undersökningar genom 
ett träningsprogram (Studie II). DT lungartärer har en hög sensitivitet vid granskning av 
subspecialiserade röntgenläkare (Studie III), men bland allmänradiologer är sensitiviteten låg 
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